01 agosto 2016
PM01183 . Phase I Study of Lurbinectedin in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors . ¡¡ This study has been completed !! .
Status : Completed .
Sponsor : PharmaMar .
Information provided by (Responsible Party) : PharmaMar .
Condition :
* Breast Cancer
* Ovarian Cancer
* Gynecological Cancer
* Head and Neck Carcinoma
* Non-small Cell Lung Cancer
* Small Cell Lung Cancer
* Non-squamous Cell Lung Cancer .
*************************************
Enrollment : 69
Study Start Date : September 2013
Study Completion Date : July 2016
Primary Completion Date : July 2016 (Final data collection date for primary outcome measure) .
*************************************
Health Authority:
* United States: Food and Drug Administration
* Spain: Agencia Española de Medicamentos y Productos Sanitarios
* Switzerland: Swissmedic .
...